Dynavax reports late stage drug trial, Q3 losses widen - Proactive Investors USA Canada PDF Print
Proactive Investors USA & Canada
About 750000 people suffer from end-stage kidney disease in the US, with roughly 150000 new cases and entry into dialysis, while roughly 35 percent of these patients do not respond to vaccination. In other news, the drug maker announced its ...
Dynavax Phase 3 Data in Chronic Kidney Disease Demonstrates Superiority of

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.